Prostate specific antigen (PSA) kinetics after 125I seed implantation (permanent Brachytherapy) for localized prostate cancer

Shin Ebara; D. Manabe; R. Tanimoto; K. Edamura; Y. Kobayashi; T. Saika; Y. Nasu; H. Kumon; T. Katayama; M. Takemoto; S. Kanazawa

Prostate specific antigen (PSA) kinetics after ¹²⁵I seed implantation (permanent Brachytherapy) for localized prostate cancer

Shin Ebara, D. Manabe, R. Tanimoto, K. Edamura, Y. Kobayashi, T. Saika, Y. Nasu, H. Kumon, T. Katayama, M. Takemoto, S. Kanazawa

Research output: Contribution to journal › Article › peer-review

Abstract

PSA bounce (over 0.1ng/ml) was observed in 25.7% of patients (18 of 70) within 30 month after brachytherapy in our series. Several reports demonstrated that PSA bounce was observed in 30-50% of patients, observed within 2 years after brachytherapy and continued following 1 year. PSA bounce should be considered when assessing a patient with a rising PSA level before PSA nadir was achieved 4-5 years after brachytherapy.

Original language	English
Pages (from-to)	641-645
Number of pages	5
Journal	Japanese Journal of Clinical Radiology
Volume	52
Issue number	5
Publication status	Published - 2007

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following Sustainable Development Goal(s)

Fingerprint Dive into the research topics of 'Prostate specific antigen (PSA) kinetics after <sup>125</sup>I seed implantation (permanent Brachytherapy) for localized prostate cancer'. Together they form a unique fingerprint.

Cite this

Prostate specific antigen (PSA) kinetics after ¹²⁵I seed implantation (permanent Brachytherapy) for localized prostate cancer. / Ebara, Shin; Manabe, D.; Tanimoto, R.; Edamura, K.; Kobayashi, Y.; Saika, T.; Nasu, Y.; Kumon, H.; Katayama, T.; Takemoto, M.; Kanazawa, S.

In: Japanese Journal of Clinical Radiology, Vol. 52, No. 5, 2007, p. 641-645.

Research output: Contribution to journal › Article › peer-review

@article{d7118083a0604808a45d4a84fd9f2e85,

title = "Prostate specific antigen (PSA) kinetics after 125I seed implantation (permanent Brachytherapy) for localized prostate cancer",

abstract = "PSA bounce (over 0.1ng/ml) was observed in 25.7% of patients (18 of 70) within 30 month after brachytherapy in our series. Several reports demonstrated that PSA bounce was observed in 30-50% of patients, observed within 2 years after brachytherapy and continued following 1 year. PSA bounce should be considered when assessing a patient with a rising PSA level before PSA nadir was achieved 4-5 years after brachytherapy.",

author = "Shin Ebara and D. Manabe and R. Tanimoto and K. Edamura and Y. Kobayashi and T. Saika and Y. Nasu and H. Kumon and T. Katayama and M. Takemoto and S. Kanazawa",

year = "2007",

language = "English",

volume = "52",

pages = "641--645",

journal = "Japanese Journal of Clinical Radiology",

issn = "0009-9252",

publisher = "Kanehara Shuppan Co. Ltd",

number = "5",

}

TY - JOUR

T1 - Prostate specific antigen (PSA) kinetics after 125I seed implantation (permanent Brachytherapy) for localized prostate cancer

AU - Ebara, Shin

AU - Manabe, D.

AU - Tanimoto, R.

AU - Edamura, K.

AU - Kobayashi, Y.

AU - Saika, T.

AU - Nasu, Y.

AU - Kumon, H.

AU - Katayama, T.

AU - Takemoto, M.

AU - Kanazawa, S.

PY - 2007

Y1 - 2007

N2 - PSA bounce (over 0.1ng/ml) was observed in 25.7% of patients (18 of 70) within 30 month after brachytherapy in our series. Several reports demonstrated that PSA bounce was observed in 30-50% of patients, observed within 2 years after brachytherapy and continued following 1 year. PSA bounce should be considered when assessing a patient with a rising PSA level before PSA nadir was achieved 4-5 years after brachytherapy.

AB - PSA bounce (over 0.1ng/ml) was observed in 25.7% of patients (18 of 70) within 30 month after brachytherapy in our series. Several reports demonstrated that PSA bounce was observed in 30-50% of patients, observed within 2 years after brachytherapy and continued following 1 year. PSA bounce should be considered when assessing a patient with a rising PSA level before PSA nadir was achieved 4-5 years after brachytherapy.

UR - http://www.scopus.com/inward/record.url?scp=34250636728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250636728&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34250636728

VL - 52

SP - 641

EP - 645

JO - Japanese Journal of Clinical Radiology

JF - Japanese Journal of Clinical Radiology

SN - 0009-9252

IS - 5